Skip Navigation


ToxSci Advance Access originally published online on December 16, 2006
Toxicological Sciences 2007 96(1):72-82; doi:10.1093/toxsci/kfl188
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
96/1/72    most recent
kfl188v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Phillips, J. M.
Right arrow Articles by Goodman, J. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Phillips, J. M.
Right arrow Articles by Goodman, J. I.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Orphan Nuclear Receptor Constitutive Active/Androstane Receptor–Mediated Alterations in DNA Methylation during Phenobarbital Promotion of Liver Tumorigenesis

Jennifer M. Phillips*, Yukio Yamamoto{dagger}, Masahiko Negishi{dagger}, Robert R. Maronpot{ddagger} and Jay I. Goodman§,1

* Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan 48824; Laboratories of {dagger} Reproductive and Developmental Toxicology and {ddagger} Experimental Pathology, NIEHS, NIH, Research Triangle Park, North Carolina 27709 § Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan 48824

1 To whom correspondence should be addressed at Department of Pharmacology and Toxicology, Michigan State University, B-440 Life Sciences Bldg., East Lansing, MI 48824. Fax: (517) 353-8915. E-mail: goodman3{at}msu.edu.

Received October 26, 2006; accepted December 12, 2006


   Abstract

Altered DNA methylation is an epigenetic mechanism that plays a key role in the carcinogenesis process, and the nongenotoxic rodent hepatocarcinogen phenobarbital (PB) alters the methylation status of DNA in mouse liver. The constitutive active/androstane nuclear receptor (CAR) mediates half of the PB-induced hepatic gene expression changes and it is essential for liver tumor promotion in PB-treated mice. Here, a technique involving methylation-sensitive restriction digestion, arbitrarily primed PCR, and capillary electrophoresis was utilized to detect PB-induced regions of altered DNA methylation (RAMs) in CAR wildtype (WT) mice that are sensitive to promotion by PB and resistant CAR knockout (KO) mice. The CAR WT mice developed preneoplastic lesions after 23 weeks of PB treatment (precancerous) and liver tumors after 32 weeks, while the CAR KO mice did not develop tumors (Y. Yamamoto, et al., 2004, Cancer Res. 64, 7197–7200). Our goal was to discern those RAMs which are playing important roles in tumor formation by comparing the RAMs that form in sensitive and resistant groups of mice. Using this novel approach, 42 unique RAMs were identified in the precancerous as compared to the CAR KO, 23-week PB-treated tissue. Of these 42 RAMs, 14 carried forward to the tumor tissue, and additionally, 104 total unique RAMs were observed in the tumor tissue. These results indicate that there are unique RAMs occurring in the sensitive CAR WT mice and that a portion of these are seen in both the precancerous and tumor tissue. We hypothesize that these unique RAMs may be facilitating the tumorigenesis process, and these data support the view that DNA methylation plays a causative role in PB-induced tumorigenesis.

Key Words: CAR; DNA methylation; mouse liver; phenobarbital; tumors.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
J. M. Phillips, L. D. Burgoon, and J. I. Goodman
The Constitutive Active/Androstane Receptor Facilitates Unique Phenobarbital-Induced Expression Changes of Genes Involved in Key Pathways in Precancerous Liver and Liver Tumors
Toxicol. Sci., August 1, 2009; 110(2): 319 - 333.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. M. Phillips, L. D. Burgoon, and J. I. Goodman
Phenobarbital Elicits Unique, Early Changes in the Expression of Hepatic Genes that Affect Critical Pathways in Tumor-Prone B6C3F1 Mice
Toxicol. Sci., June 1, 2009; 109(2): 193 - 205.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. M. Phillips and J. I. Goodman
Multiple Genes Exhibit Phenobarbital-Induced Constitutive Active/Androstane Receptor-Mediated DNA Methylation Changes during Liver Tumorigenesis and in Liver Tumors
Toxicol. Sci., April 1, 2009; 108(2): 273 - 289.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. Gupta, M. Venkatesh, H. Wang, S. Kim, M. Sinz, G. L. Goldberg, K. Whitney, C. Longley, and S. Mani
Expanding the Roles for Pregnane X Receptor in Cancer: Proliferation and Drug Resistance in Ovarian Cancer
Clin. Cancer Res., September 1, 2008; 14(17): 5332 - 5340.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. M. Phillips and J. I. Goodman
Identification of Genes that May Play Critical Roles in Phenobarbital (PB)-Induced Liver Tumorigenesis due to Altered DNA Methylation
Toxicol. Sci., July 1, 2008; 104(1): 86 - 99.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.